Company to Also Provide Operational and Regulatory Updates
DURHAM, N.C., April 24 /PRNewswire-FirstCall/ --
Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today that it will
hold a conference call on Thursday, May 2 at 11:00 a.m. EDT to discuss its
financial results for the first quarter of 2002. These results are expected
to be released after the market closes on Tuesday, April 30, 2002. During the
call, management will also provide updated operational and regulatory
information related to its drug candidates.
Interested parties in the U.S. may join the call toll free by dialing
877-679-9045. International callers may join the call by dialing
952-556-2802. The confirmation number is 5965732.
The call will be webcast on the Triangle Pharmaceuticals Web site at
http://www.tripharm.com and archived for replay on the site for one week after the
call. Slides accompanying the presentation may also be accessed on the
website.
SOURCE Triangle Pharmaceuticals, Inc.
 back to top
Related links:
http://www.tripharm.com
CONTACT:
Robert Amundsen, Executive Vice President,
Chief Financial Officer, or Chris Rallis, President, Chief
Operating Officer, of Triangle Pharmaceuticals, Inc.,
+1-919-493-5980
|
